EEF1A2 and neoplasm: In all groups of animals treated with a high dose (25 μg) of Statin AE transposon DNA, there was a significant reduction in the number of liver tumor nodules in comparison with that of untreated tumor bearing animals (P < 0.05), whether or not SB transposase plasmid was co-injected (Figure 4A).